These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27648944)

  • 1. Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than "miR" Words.
    Chun HJ; Bonnet S; Chan SY
    Am J Respir Crit Care Med; 2017 Jan; 195(2):167-178. PubMed ID: 27648944
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.
    Deng L; Blanco FJ; Stevens H; Lu R; Caudrillier A; McBride M; McClure JD; Grant J; Thomas M; Frid M; Stenmark K; White K; Seto AG; Morrell NW; Bradshaw AC; MacLean MR; Baker AH
    Circ Res; 2015 Oct; 117(10):870-883. PubMed ID: 26311719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1.
    Baptista R; Marques C; Catarino S; Enguita FJ; Costa MC; Matafome P; Zuzarte M; Castro G; Reis A; Monteiro P; Pêgo M; Pereira P; Girão H
    Cardiovasc Res; 2018 Jan; 114(1):53-64. PubMed ID: 29016730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics: novel mechanism of pulmonary hypertension.
    Huang JB; Liang J; Zhao XF; Wu WS; Zhang F
    Lung; 2013 Dec; 191(6):601-10. PubMed ID: 24052023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-103/107 is involved in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by targeting HIF-1β.
    Deng B; Du J; Hu R; Wang AP; Wu WH; Hu CP; Li YJ; Li XH
    Life Sci; 2016 Feb; 147():117-24. PubMed ID: 26827991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension.
    Potus F; Malenfant S; Graydon C; Mainguy V; Tremblay È; Breuils-Bonnet S; Ribeiro F; Porlier A; Maltais F; Bonnet S; Provencher S
    Am J Respir Crit Care Med; 2014 Aug; 190(3):318-28. PubMed ID: 24977625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
    Hong Z; Chen KH; DasGupta A; Potus F; Dunham-Snary K; Bonnet S; Tian L; Fu J; Breuils-Bonnet S; Provencher S; Wu D; Mewburn J; Ormiston ML; Archer SL
    Am J Respir Crit Care Med; 2017 Feb; 195(4):515-529. PubMed ID: 27648837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human lung microRNA profiling in pulmonary arterial hypertension secondary to congenital heart defect.
    Ma K; Zhao Q; Chen W; Zhang H; Li S; Pan X; Chen Q
    Pediatr Pulmonol; 2015 Dec; 50(12):1214-23. PubMed ID: 25847058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Potential of microRNA Modulation in Pulmonary Arterial Hypertension.
    Meloche J; Paulin R; Provencher S; Bonnet S
    Curr Vasc Pharmacol; 2015; 13(3):331-40. PubMed ID: 23713859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.
    Austin ED; West J; Loyd JE; Hemnes AR
    Am J Respir Crit Care Med; 2017 Jan; 195(1):23-31. PubMed ID: 27398627
    [No Abstract]   [Full Text] [Related]  

  • 11. miR-190a-5p participates in the regulation of hypoxia-induced pulmonary hypertension by targeting KLF15 and can serve as a biomarker of diagnosis and prognosis in chronic obstructive pulmonary disease complicated with pulmonary hypertension.
    Jiang J; Xia Y; Liang Y; Yang M; Zeng W; Zeng X
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3777-3790. PubMed ID: 30538440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment.
    Bienertova-Vasku J; Novak J; Vasku A
    J Am Soc Hypertens; 2015 Mar; 9(3):221-34. PubMed ID: 25660363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension.
    Gubrij IB; Pangle AK; Pang L; Johnson LG
    PLoS One; 2016; 11(1):e0147827. PubMed ID: 26815432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling.
    Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP
    Life Sci; 2019 Jun; 227():64-73. PubMed ID: 31004656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs in Hypertension.
    Jusic A; Devaux Y;
    Hypertension; 2019 Sep; 74(3):477-492. PubMed ID: 31352819
    [No Abstract]   [Full Text] [Related]  

  • 16. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach.
    Parikh VN; Jin RC; Rabello S; Gulbahce N; White K; Hale A; Cottrill KA; Shaik RS; Waxman AB; Zhang YY; Maron BA; Hartner JC; Fujiwara Y; Orkin SH; Haley KJ; Barabási AL; Loscalzo J; Chan SY
    Circulation; 2012 Mar; 125(12):1520-32. PubMed ID: 22371328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.
    Aliotta JM; Pereira M; Wen S; Dooner MS; Del Tatto M; Papa E; Goldberg LR; Baird GL; Ventetuolo CE; Quesenberry PJ; Klinger JR
    Cardiovasc Res; 2016 Jun; 110(3):319-30. PubMed ID: 26980205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for miR-204 in human pulmonary arterial hypertension.
    Courboulin A; Paulin R; Giguère NJ; Saksouk N; Perreault T; Meloche J; Paquet ER; Biardel S; Provencher S; Côté J; Simard MJ; Bonnet S
    J Exp Med; 2011 Mar; 208(3):535-48. PubMed ID: 21321078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease severity-related alterations of cardiac microRNAs in experimental pulmonary hypertension.
    Kmecova Z; Veteskova J; Lelkova-Zirova K; Bies Pivackova L; Doka G; Malikova E; Paulis L; Krenek P; Klimas J
    J Cell Mol Med; 2020 Jun; 24(12):6943-6951. PubMed ID: 32395887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Featured Article: microRNA-125a in pulmonary hypertension: Regulator of a proliferative phenotype of endothelial cells.
    Huber LC; Ulrich S; Leuenberger C; Gassmann M; Vogel J; von Blotzheim LG; Speich R; Kohler M; Brock M
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1580-9. PubMed ID: 25854878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.